Activated PI3K Delta Syndrome
3 clinical trials · Condition
◉ Watch Activated PI3K Delta Syndrome
| Record | Firm | Date |
|---|---|---|
| Rapamycin Treatment for Activated Phosphoinositide 3-Kinase δ Syndrome (NCT03383380) | Children's Hospital of Fudan University | 2017-12-01 |
| Safety, Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Repeat Doses of Inhaled Nemiralisib in Patients With APDS/PASLI (NCT02593539) | GlaxoSmithKline | 2016-07-22 |
Track Activated PI3K Delta Syndrome automatically
Every clearance here is in the API, with alerts when new ones post.